Doctors track how a drug manages dangerous potassium levels
NCT ID NCT06185660
Summary
This study aimed to understand how doctors in Greece treat patients with high potassium levels (hyperkalaemia) who also have kidney disease or heart failure. Researchers observed the real-world use of a medication called sodium zirconium cyclosilicate in about 120 patients over six months. The goal was to learn about patient characteristics and how doctors manage this condition in everyday practice, without testing a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Alexandroupoli, 68100, Greece
-
Research Site
Athens, 10676, Greece
-
Research Site
Athens, 11527, Greece
-
Research Site
Athens, 12462, Greece
-
Research Site
Athens, 15123, Greece
-
Research Site
Heraklion, 71500, Greece
-
Research Site
Larissa, 41110, Greece
-
Research Site
Pátrai, 26504, Greece
-
Research Site
Thessaloniki, 54636, Greece
-
Research Site
Thessaloniki, 57010, Greece
Conditions
Explore the condition pages connected to this study.